JP2002533397A5 - - Google Patents

Download PDF

Info

Publication number
JP2002533397A5
JP2002533397A5 JP2000590640A JP2000590640A JP2002533397A5 JP 2002533397 A5 JP2002533397 A5 JP 2002533397A5 JP 2000590640 A JP2000590640 A JP 2000590640A JP 2000590640 A JP2000590640 A JP 2000590640A JP 2002533397 A5 JP2002533397 A5 JP 2002533397A5
Authority
JP
Japan
Prior art keywords
methyl
oxo
azepan
amide
ylcarbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000590640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002533397A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/030730 external-priority patent/WO2000038687A1/en
Publication of JP2002533397A publication Critical patent/JP2002533397A/ja
Publication of JP2002533397A5 publication Critical patent/JP2002533397A5/ja
Pending legal-status Critical Current

Links

JP2000590640A 1998-12-23 1999-12-21 プロテアーゼ阻害剤 Pending JP2002533397A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11363698P 1998-12-23 1998-12-23
US60/113,636 1998-12-23
US16458199P 1999-11-10 1999-11-10
US60/164,581 1999-11-10
PCT/US1999/030730 WO2000038687A1 (en) 1998-12-23 1999-12-21 Protease inhibitors

Publications (2)

Publication Number Publication Date
JP2002533397A JP2002533397A (ja) 2002-10-08
JP2002533397A5 true JP2002533397A5 (https=) 2006-09-07

Family

ID=26811293

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000590640A Pending JP2002533397A (ja) 1998-12-23 1999-12-21 プロテアーゼ阻害剤

Country Status (24)

Country Link
US (2) US20020147188A1 (https=)
EP (1) EP1158986A4 (https=)
JP (1) JP2002533397A (https=)
KR (1) KR100630986B1 (https=)
CN (1) CN1253441C (https=)
AT (1) ATE411294T1 (https=)
AU (1) AU768565B2 (https=)
BR (1) BR9916488A (https=)
CA (1) CA2356671A1 (https=)
CZ (1) CZ20012277A3 (https=)
DE (1) DE69939752D1 (https=)
DZ (1) DZ2977A1 (https=)
ES (1) ES2315456T3 (https=)
GC (1) GC0000178A (https=)
HK (1) HK1043536A1 (https=)
HU (1) HUP0104768A3 (https=)
IL (2) IL143142A0 (https=)
NO (1) NO318910B1 (https=)
NZ (1) NZ511710A (https=)
PE (1) PE20001340A1 (https=)
PL (1) PL350132A1 (https=)
TR (1) TR200101869T2 (https=)
UY (1) UY25874A1 (https=)
WO (1) WO2000038687A1 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
JP2003513971A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
EP1231922A4 (en) * 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
WO2001034566A2 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EP1233771A4 (en) * 1999-11-10 2003-05-14 Smithkline Beecham Corp PROTEASE INHIBITORS
JP2003513921A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
EP1229914A4 (en) * 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
WO2001034160A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
JP2003513925A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
WO2001034565A2 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
JP2003513926A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
WO2001034154A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
KR20020082896A (ko) * 2000-03-21 2002-10-31 스미스클라인 비참 코포레이션 프로테아제 억제제
CO5280093A1 (es) * 2000-04-18 2003-05-30 Smithkline Beecham Corp Metodos de tratamiento
CO5280088A1 (es) * 2000-04-18 2003-05-30 Smithkline Beecham Corp Inhibidores de proteasa
AU2001268407A1 (en) * 2000-06-14 2001-12-24 Smithkline Beecham Corporation Protease inhibitors
JP2004509083A (ja) * 2000-09-01 2004-03-25 スミスクライン・ビーチャム・コーポレイション 治療方法
CA2436850A1 (en) * 2000-11-22 2003-07-03 Smithkline Beecham Corporation Protease inhibitors
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
CA2437409C (en) 2001-02-20 2010-10-19 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
EP1401453A4 (en) * 2001-05-17 2005-04-06 Smithkline Beecham Corp PROTEASE INHIBITORS
US6982263B2 (en) 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
WO2003097593A2 (en) * 2002-05-22 2003-11-27 Smithkline Beecham Corporation Protease inhibitors
AU2003233642A1 (en) * 2002-05-22 2003-12-12 Smithkline Beecham Corporation Protease inhibitors
KR100962972B1 (ko) 2002-07-26 2010-06-09 주식회사유한양행 1-페닐피페리딘-3-온 유도체 및 그의 제조방법
EP1551823A1 (en) * 2002-10-08 2005-07-13 Merck Frosst Canada Inc. 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis
EP4101846B1 (en) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
CA2533747C (en) * 2003-08-01 2012-11-13 Chugai Seiyaku Kabushiki Kaisha Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
CA2533749C (en) 2003-08-01 2012-07-10 Chugai Seiyaku Kabushiki Kaisha Piperidine compounds useful as malonyl-coa decarboxylase inhibitors
US7786145B2 (en) 2003-08-01 2010-08-31 Chugai Seiyaku Kabushiki Kaisha Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors
JP2007517810A (ja) * 2004-01-08 2007-07-05 メルク フロスト カナダ リミテツド カテプシンシステインプロテアーゼ阻害剤
JP2008512461A (ja) * 2004-09-07 2008-04-24 スミスクライン・ビーチャム・コーポレイション 新規化合物
WO2007012180A1 (en) * 2005-07-26 2007-02-01 Merck Frosst Canada Ltd. Papain family cysteine protease inhibitors for the treatment of parasitic diseases
EP2387995A1 (en) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
CN103687593B (zh) 2011-05-16 2016-09-28 拜耳知识产权有限责任公司 组织蛋白酶k抑制用于治疗和/或预防肺动脉高压和/或心力衰竭的用途
CN103275070A (zh) * 2013-05-10 2013-09-04 郑彪 调节单核细胞增殖的四环化合物及其应用
TWI695717B (zh) 2014-03-06 2020-06-11 美商 Ptc 治療公司 1,2,4-二唑苯甲酸之鹽及醫藥組合物
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1195287B (it) * 1981-11-05 1988-10-12 Ausonia Farma Srl Derivato tiazolico,procedimento per la sua preparazione e relative composizioni farmaceutiche
JPH05140063A (ja) * 1991-11-19 1993-06-08 Suntory Ltd ジペプチド誘導体及びそれを有効成分とする骨疾患の予防及び治療剤
CA2111930A1 (en) * 1992-12-25 1994-06-26 Ryoichi Ando Aminoketone derivatives
DE69321087T2 (de) * 1992-12-25 1999-05-20 Mitsubishi Chemical Corp., Tokio/Tokyo Alpha-aminoketon Derivate
JPH06199850A (ja) * 1992-12-28 1994-07-19 Tanabe Seiyaku Co Ltd インドール含有ペプチド及びその製法
DE69612962T2 (de) * 1995-12-12 2001-11-15 Taiho Pharmaceutical Co. Ltd., Tokio/Tokyo Epoxysuccinamid-derivate oder deren salze und medikamente die diese enthalten
US5902882A (en) * 1996-04-17 1999-05-11 Hoffmann-La Roche Inc. Assymetric synthesis of azepines
DZ2285A1 (fr) * 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
US6107291A (en) * 1997-12-19 2000-08-22 Amgen Inc. Azepine or larger medium ring derivatives and methods of use
WO2001034566A2 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034154A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
JP2003513921A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
JP2003513926A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
WO2001034565A2 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
JP2003513971A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
US6583137B1 (en) * 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
EP1229914A4 (en) * 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
WO2001034160A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EP1233771A4 (en) * 1999-11-10 2003-05-14 Smithkline Beecham Corp PROTEASE INHIBITORS
NL1013996C2 (nl) * 1999-12-30 2001-07-03 Innas Free Piston Bv Vrijezuiger aggregaat voor opwekken van hydraulische energie.

Similar Documents

Publication Publication Date Title
JP2002533397A5 (https=)
JP2003527429A5 (https=)
CA2356671A1 (en) Protease inhibitors
US8518973B2 (en) Compounds having 4-pyridylalkylthio group as a substituent
RU2004138079A (ru) Антагонисты рецептора-1 меланин-концентрирующего гормона (мсн1r)
CN101027295A (zh) 用于治疗炎性疾病的化合物和含它们的药物组合物
AU7288598A (en) Protease inhibitors
NZ518698A (en) Novel cyclopropanes as CGRP antagonists, medicaments containing said compounds and method for the production thereof
OA12323A (en) Protease inhibitors.
ZA200206361B (en) Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists.
EP1320370A1 (en) Method of treatment
JP2015520224A5 (https=)
CA2412353A1 (en) Protease inhibitors
IE61963B1 (en) Indan derivatives and process for preparation thereof
US7405209B2 (en) Protease inhibitors
ZA200104208B (en) Protease inhibitors.
EP1392657A2 (en) Protease inhibitors
JP2005232149A (ja) 4−ピリジルアルキルチオ基を置換基として有する新規化合物
US20030044399A1 (en) Method of treatment
EP1289980A1 (en) Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
MXPA01006613A (en) Protease inhibitors
US20040038965A1 (en) Protease inhibitors